Related Experiment Video
Updated: Aug 16, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
The PLAGL1 gene is down-regulated in human extraskeletal myxoid chondrosarcoma tumors
1Unité de recherche en génétique humaine et moléculaire, Hôpital Saint-François d'Assise, CHUQ, Que., Canada G1L 3L5.
Abstract:
In approximately 70% of human extraskeletal myxoid chondrosarcoma (EMC) tumors, a t(9;22) chromosome translocation gives rise to a fusion protein, named EWS/NOR1, containing the amino-terminal domain of EWS fused to the complete amino acid sequence of the nuclear receptor NOR1. Several observations suggest that one role of EWS/NOR1 in EMC may be to deregulate the expression of specific genes involved in the tumoral process. In order to identify these genes, we have used a CFK2 chondrogenic cell line over-expressing EWS/NOR1. A differential display analysis has identified the PLAGL1 gene as being down-regulated in the CFK2(EWS/NOR1) cell line compared to native CFK2 cells. RT-PCR analyses show that whereas the PLAGL1 mRNAs encoding the two isoforms of the protein are highly expressed in four human chondrocyte immortalized cell lines and two human chondrocyte primary cultures, they are strongly down-regulated in six EMC tumors. We conclude that down-regulation of PLAGL1 may be a significant contributing factor in the development of EMC tumors.
Insights
The EWS/NOR1 fusion protein in extraskeletal myxoid chondrosarcoma (EMC) down-regulates the PLAGL1 gene. This PLAGL1 gene down-regulation may contribute to EMC tumor development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Extraskeletal myxoid chondrosarcoma (EMC) is a rare soft tissue sarcoma.
- A t(9;22) chromosome translocation producing the EWS/NOR1 fusion protein occurs in ~70% of EMC cases.
- The EWS/NOR1 fusion protein is hypothesized to deregulate gene expression in EMC.
Purpose of the Study:
- To identify genes whose expression is altered by the EWS/NOR1 fusion protein.
- To investigate the role of PLAGL1 in the pathogenesis of EMC.
Main Methods:
- Differential display analysis was performed on a chondrogenic cell line overexpressing EWS/NOR1 (CFK2(EWS/NOR1)) compared to control cells (CFK2).
- Reverse transcription polymerase chain reaction (RT-PCR) was used to analyze PLAGL1 mRNA expression.
- PLAGL1 expression was assessed in immortalized chondrocyte cell lines, primary chondrocyte cultures, and EMC tumors.
Main Results:
- Differential display identified the PLAGL1 gene as down-regulated in CFK2(EWS/NOR1) cells.
- RT-PCR confirmed strong down-regulation of PLAGL1 mRNA isoforms in six human EMC tumors.
- PLAGL1 mRNA was highly expressed in normal human chondrocyte cell lines and primary cultures.
Conclusions:
- Down-regulation of the PLAGL1 gene is observed in human EMC tumors.
- PLAGL1 down-regulation may be a significant factor in the development of extraskeletal myxoid chondrosarcoma.
Related Concept Videos
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Induced Pluripotent Stem Cells
Somatic cells are...
Epigenetic Regulation
